Mossop H

Latest

A randomised assessment of image guided radiotherapy within a phase 3 trial of conventional or hypofractionated high dose intensity modulated radiotherapy for prostate cancer
The association between vitamin D status and clinical events in high-risk older patients with non-ST elevation acute coronary syndrome undergoing invasive management
Brief alcohol intervention for risky drinking in young people aged 14–15 years in secondary schools: The SIPS JR-HIGH RCT
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis
Cognitive decline in older patients with non-ST elevation acute coronary syndrome
ALternatives To prophylactic Antibiotics for the treatment of Recurrent urinary tract infection in women (ALTAR): Study protocol for a multicentre, pragmatic, patient-randomised, non-inferiority trial
Factors associated with physical performance measures in a multiethnic cohort of older adults
Clinical outcome of prostate cancer patients with germline DNA repair mutations: Retrospective analysis from an international study
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition
5-year patient-reported outcomes of bowel and urinary bother in the CHHiP trial (CRUK/06/016)
Do routine computed tomography scans detect early spinal cord compression in patients with castrate resistant prostate cancer? Implications for the PROMPTS trial
Effect of dose to the penile bbulb on erectile potency (EP) in prostate image-guided radiotherapy (IGRT)
Diffusion-weighted imaging as a treatment response biomarker for evaluating bone metastases in prostate cancer: A pilot study
Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
Hypofractionated radiotherapy versus conventionally fractionated radiotherapy for patients with intermediate-risk localised prostate cancer: 2-year patient-reported outcomes of the randomised, non-inferiority, phase 3 CHHiP trial
DNA-repair defects and olaparib in metastatic prostate cancer
Evaluation of erectile potency and radiation dose to the penile bulb using image guided radiotherapy in the CHHiP trial